These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 38411156)

  • 1. PML Nuclear bodies: the cancer connection and beyond.
    Abou-Ghali M; Lallemand-Breitenbach V
    Nucleus; 2024 Dec; 15(1):2321265. PubMed ID: 38411156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PML Body Biogenesis: A Delicate Balance of Interactions.
    Silonov SA; Smirnov EY; Kuznetsova IM; Turoverov KK; Fonin AV
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
    Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M
    J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the Prevalence and Roles of Proteins Undergoing Liquid-Liquid Phase Separation in the Biogenesis of PML-Bodies.
    Silonov SA; Mokin YI; Nedelyaev EM; Smirnov EY; Kuznetsova IM; Turoverov KK; Uversky VN; Fonin AV
    Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure.
    Ablain J; Rice K; Soilihi H; de Reynies A; Minucci S; de Thé H
    Nat Med; 2014 Feb; 20(2):167-74. PubMed ID: 24412926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional roles of PML nuclear bodies in genome maintenance.
    Chang HR; Munkhjargal A; Kim MJ; Park SY; Jung E; Ryu JH; Yang Y; Lim JS; Kim Y
    Mutat Res; 2018 May; 809():99-107. PubMed ID: 28521962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML Bodies in Mitosis.
    Lång A; Lång E; Bøe SO
    Cells; 2019 Aug; 8(8):. PubMed ID: 31416160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism.
    Tessier S; Martin-Martin N; de Thé H; Carracedo A; Lallemand-Breitenbach V
    Antioxid Redox Signal; 2017 Mar; 26(9):432-444. PubMed ID: 27758112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promyelocytic leukemia nuclear body: sites of activity?
    Eskiw CH; Bazett-Jones DP
    Biochem Cell Biol; 2002; 80(3):301-10. PubMed ID: 12123283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Evidence of the Importance of Weak Interactions in the Formation of PML-Bodies.
    Fonin AV; Silonov SA; Fefilova AS; Stepanenko OV; Gavrilova AA; Petukhov AV; Romanovich AE; Modina AL; Zueva TS; Nedelyaev EM; Pleskach NM; Kuranova ML; Kuznetsova IM; Uversky VN; Turoverov KK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling.
    Lång E; Grudic A; Pankiv S; Bruserud O; Simonsen A; Bjerkvig R; Bjørås M; Bøe SO
    Blood; 2012 Jul; 120(4):847-57. PubMed ID: 22692509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promyelocytic leukemia nuclear bodies support a late step in DNA double-strand break repair by homologous recombination.
    Yeung PL; Denissova NG; Nasello C; Hakhverdyan Z; Chen JD; Brenneman MA
    J Cell Biochem; 2012 May; 113(5):1787-99. PubMed ID: 22213200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unravelling the molecular interplay: SUMOylation, PML nuclear bodies and vascular cell activity in health and disease.
    Berkholz J; Karle W
    Cell Signal; 2024 Jul; 119():111156. PubMed ID: 38574938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies.
    Hirano S; Udagawa O
    PLoS One; 2022; 17(5):e0268835. PubMed ID: 35594310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
    Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
    Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RING tetramerization is required for nuclear body biogenesis and PML sumoylation.
    Wang P; Benhenda S; Wu H; Lallemand-Breitenbach V; Zhen T; Jollivet F; Peres L; Li Y; Chen SJ; Chen Z; de Thé H; Meng G
    Nat Commun; 2018 Mar; 9(1):1277. PubMed ID: 29599493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Regad T; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells.
    Müller S; Miller WH; Dejean A
    Blood; 1998 Dec; 92(11):4308-16. PubMed ID: 9834237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology.
    Zhu G
    Curr Pharm Biotechnol; 2013; 14(9):849-58. PubMed ID: 24433507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies.
    de Thé H; Le Bras M; Lallemand-Breitenbach V
    J Cell Biol; 2012 Jul; 198(1):11-21. PubMed ID: 22778276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.